Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Anuh Pharma

Sector: Healthcare | Industry: Drugs & Pharma
R 139.65 -2.35  | -1.65% -8.06% 14.86 349.91
BSE Price: Oct 15, 2019 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
BSE Oct 15, 2019 139.65 -2.35 -1.65% 140.00 142.00 1,246 139.00 - 143.55
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE FREE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 5,890 P/B: 2.05 NSE Code:
52-Week Range: R 101.25 - 173.00 Dividend Yield: 1.97% BSE Code: 506260
TTM EPS: R 9.40 Book Value: R 68.04 Face Value: R 5
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 38
Price Graph
  • Eris Lifesciences (BSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Our equity analyst team has sifted through hundreds of companies and selected a short list of stocks that you should invest in.
This list now has 38 stocks on it. Thousands of our members are using stagnant equity markets to buy great stocks at low prices.

Membership is currently available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Anuh Pharma -12.55 -10.51 10.83 -8.06 -16.08 6.46 14.76
S&P BSE Small Cap* -13.05 -1.73 -7.18 -9.64 -0.99 3.76 5.39
S&P BSE Healthcare* -11.96 -5.87 -5.15 -15.12 -8.79 -2.02 10.48
Company's return has been calculated on basis of BSE's price.
As on Oct 15, 2019
*As on Oct 14, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 34.68 -0.57 3.78
Net Profit 41.51 -3.25 5.84
EPS 41.51 -3.25 5.84
Book Value 10.02 11.33 13.90
Average
Operating Margin 10.81 12.10 12.32
Net Margin 7.18 7.76 7.75
Return on Networth 14.87 13.90 17.73
Return on Investment 20.56 19.49 25.70
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue 2.22 5.78 2.22
Operating Profit 4.05 11.44 4.05
Net Profit 10.54 3.11 10.54
EPS 10.54 3.11 10.54
TTM
Revenue 1.45 22.30 1.45
Operating Profit 2.69 39.23 2.69
Net Profit 0.76 47.58 0.76
EPS 0.76 47.57 0.76
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Anuh Pharma 349.91 325.31 23.54 7.13 14.87 2.05 14.86
Astrazeneca Pharma India 5,337.38 771.42 69.56 8.84 20.03 16.67 76.73
Eris Lifesciences 5,801.96 1,005.70 303.64 29.29 28.96 4.70 19.11
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Aug 13, 2019 Bharat Nemchand Shah  Buy Market 10,872 128.40 13.96
Aug 13, 2019 Bharat Nemchand Shah  Buy Market 9,241 128.40 11.87
Aug 13, 2019 Ketan Lalit Shah  Buy Market 50,000 128.40 64.20
Jan 21, 2019 Bharat Nemchand Shah  Buy Market 14,060 156.55 22.01
Jan 03, 2019 Bharat Nemchand Shah  Buy Market 8,149 156.00 12.71
Fund Houses invested in the stock
Fund Sep-07 Jun-07 Mar-07 Dec-06 Sep-06
Nippon India Mutual Fund 4.099 4.423 4.447 8.895 8.896
Figures given above are % of equity capital
News & Announcements
Contact Information

Company: Anuh Pharma Ltd.

Address: 3 - A, Shivsasgar Estate, North Wing, Dr. Annie Basant Road, Worli, Mumbai, Maharashtra - 400018 | Phone: +91-22-66227575 | Fax: +91-22-66227600

Email: [email protected]

Website: www.anuhpharma.com

Registrar & Transfer Agent: Bigshare Services Pvt Ltd

Address: Bharat Tin Works building, 1st floor, Opp. Vasant Oasis, Andheri East Mumbai - 400 059Tel: + 91 21 626 38200Fax: +91 21 62638299(Old Address) E-2&3 , Ansa Industrial Estate,Saki Vihar Road,Saki Naka, Andheri (E),Mumbai, Bharat Tin Works Building, 1st floor, Opp. Vasant Oasis, Andheri (E) | Phone: 91-022-62638200 | Fax: 91-022-62638299

Email: [email protected]

Essential checks
Altman Z-Score
5.85
Piotroski F-Score
6
Modified C-Score
3
5-Years Price to Earnings
14.86
5-Years Price to Book
2.05
Earnings Yield
EBIT / Enterprise value
9.85%
PEG
Price / Earnings to growth ratio
5.71
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,134.25 -1.66%
Caplin Point Laboratories R398.40 -0.91%
Eris Lifesciences R424.80 -1.72%
FDC R159.35 -0.50%
JB Chemicals & Pharma R356.05 -0.96%
Laurus Labs R319.55 -0.11%
Strides Pharma Science R355.60 +5.05%
Sun Pharma Adv. Research R119.90 +0.88%
Suven Life Sciences R265.70 +2.90%
Wockhardt R253.55 -0.06%
As on Oct 15, 15:59